![American Association for Cancer Research (AACR) 2020 Virtual Meeting II – Poster | Sutro Biopharma, Inc. American Association for Cancer Research (AACR) 2020 Virtual Meeting II – Poster | Sutro Biopharma, Inc.](https://www.sutrobio.com/wp-content/uploads/2020/06/STRO-002-AACR-2020-Virtual-Meeting-II-Poster-.gif)
American Association for Cancer Research (AACR) 2020 Virtual Meeting II – Poster | Sutro Biopharma, Inc.
![Download our posters presented at the AACR Virtual Annual Meeting 2020 - by Explicyte Immuno-Oncology Download our posters presented at the AACR Virtual Annual Meeting 2020 - by Explicyte Immuno-Oncology](https://explicyte.com/media/9272.png)
Download our posters presented at the AACR Virtual Annual Meeting 2020 - by Explicyte Immuno-Oncology
![REPEAT/Greenwich LifeSciences Presents Phase IIb Poster, Published April 10th at 2021 AACR Annual Meeting, Showing GP2 Immune Response Peaked at 6 Months, Resulting in 100% Disease Free Survival from Recurring Breast Cancer REPEAT/Greenwich LifeSciences Presents Phase IIb Poster, Published April 10th at 2021 AACR Annual Meeting, Showing GP2 Immune Response Peaked at 6 Months, Resulting in 100% Disease Free Survival from Recurring Breast Cancer](https://mms.businesswire.com/media/20210412005340/en/870545/5/Fig1-3hc.jpg)
REPEAT/Greenwich LifeSciences Presents Phase IIb Poster, Published April 10th at 2021 AACR Annual Meeting, Showing GP2 Immune Response Peaked at 6 Months, Resulting in 100% Disease Free Survival from Recurring Breast Cancer
![AACR 2021 Poster: RNA-Based Diagnostic Panel Matches TME Phenotype to Therapeutic Mechanism of Action in Colorectal Cancer - Genialis AACR 2021 Poster: RNA-Based Diagnostic Panel Matches TME Phenotype to Therapeutic Mechanism of Action in Colorectal Cancer - Genialis](https://www.genialis.com/wp-content/uploads/2021/04/OncXerna-AACRPoster.png)
AACR 2021 Poster: RNA-Based Diagnostic Panel Matches TME Phenotype to Therapeutic Mechanism of Action in Colorectal Cancer - Genialis
![AACR 2021 : Domain Therapeutics to present posters on last developments in the field of oncology - Domain Therapeutics Group AACR 2021 : Domain Therapeutics to present posters on last developments in the field of oncology - Domain Therapeutics Group](http://www.domaintherapeutics.com/wp-content/uploads/2021/04/DomainTxTplte-Re%CC%81cupe%CC%81re%CC%81-03-1024x523.png)
AACR 2021 : Domain Therapeutics to present posters on last developments in the field of oncology - Domain Therapeutics Group
![AACR 2021: Dual-specific biotherapeutics targeting BCMA and TACI have the potential to overcome resistance mechanisms in multiple Myeloma | Hummingbird Bioscience AACR 2021: Dual-specific biotherapeutics targeting BCMA and TACI have the potential to overcome resistance mechanisms in multiple Myeloma | Hummingbird Bioscience](https://hummingbirdbioscience.com/wp-content/uploads/2022/11/Dual-specific-biotherapeutics-targeting-BCMA-and-TACI-have-the-potential-to-overcome-resistance-mechanisms-in-multiple-Myeloma-1.jpg)
AACR 2021: Dual-specific biotherapeutics targeting BCMA and TACI have the potential to overcome resistance mechanisms in multiple Myeloma | Hummingbird Bioscience
![VBI Vaccines Announces Data from VBI-1901 Presented at AACR 2020: Partial Response Observed, Promising Biomarker Strategy Identified - VBI Vaccines VBI Vaccines Announces Data from VBI-1901 Presented at AACR 2020: Partial Response Observed, Promising Biomarker Strategy Identified - VBI Vaccines](https://www.vbivaccines.com/wp-content/uploads/2020/06/AACR-2020-Poster.png)